A detailed history of O'Shaughnessy Asset Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 206,484 shares of AZN stock, worth $13.3 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
206,484
Previous 147,015 40.45%
Holding current value
$13.3 Million
Previous $11.5 Million 40.33%
% of portfolio
0.15%
Previous 0.12%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$76.67 - $87.62 $4.56 Million - $5.21 Million
59,469 Added 40.45%
206,484 $16.1 Million
Q2 2024

Aug 14, 2024

BUY
$66.81 - $80.83 $2.36 Million - $2.86 Million
35,356 Added 31.66%
147,015 $11.5 Million
Q1 2024

May 13, 2024

BUY
$61.03 - $69.57 $1.04 Million - $1.18 Million
16,966 Added 17.92%
111,659 $7.56 Million
Q4 2023

Feb 09, 2024

BUY
$61.89 - $69.28 $450,744 - $504,566
7,283 Added 8.33%
94,693 $6.38 Million
Q3 2023

Nov 13, 2023

BUY
$64.85 - $71.7 $310,955 - $343,801
4,795 Added 5.8%
87,410 $5.92 Million
Q2 2023

Aug 11, 2023

BUY
$69.91 - $75.81 $600,387 - $651,056
8,588 Added 11.6%
82,615 $5.91 Million
Q1 2023

May 12, 2023

SELL
$63.15 - $71.6 $24,691 - $27,995
-391 Reduced 0.53%
74,027 $5.14 Million
Q4 2022

Feb 10, 2023

BUY
$54.21 - $70.44 $713,783 - $927,483
13,167 Added 21.5%
74,418 $5.05 Million
Q3 2022

Nov 14, 2022

SELL
$53.02 - $135.75 $383,069 - $980,793
-7,225 Reduced 10.55%
61,251 $3.36 Million
Q2 2022

Aug 11, 2022

BUY
$59.26 - $71.14 $362,493 - $435,163
6,117 Added 9.81%
68,476 $4.52 Million
Q1 2022

May 13, 2022

BUY
$55.72 - $67.12 $1.09 Million - $1.31 Million
19,479 Added 45.43%
62,359 $4.14 Million
Q4 2021

Feb 11, 2022

BUY
$54.02 - $63.83 $59,584 - $70,404
1,103 Added 2.64%
42,880 $2.5 Million
Q3 2021

Nov 10, 2021

BUY
$55.56 - $60.79 $561,433 - $614,282
10,105 Added 31.91%
41,777 $2.51 Million
Q2 2021

Aug 09, 2021

SELL
$48.42 - $60.18 $177,459 - $220,559
-3,665 Reduced 10.37%
31,672 $1.9 Million
Q1 2021

May 14, 2021

BUY
$47.16 - $54.44 $535,926 - $618,656
11,364 Added 47.4%
35,337 $1.76 Million
Q4 2020

Feb 11, 2021

SELL
$48.52 - $58.02 $424,647 - $507,791
-8,752 Reduced 26.74%
23,973 $1.2 Million
Q3 2020

Nov 12, 2020

BUY
$53.07 - $61.1 $105,609 - $121,589
1,990 Added 6.47%
32,725 $1.79 Million
Q2 2020

Aug 13, 2020

BUY
$43.1 - $55.31 $790,410 - $1.01 Million
18,339 Added 147.94%
30,735 $1.63 Million
Q1 2020

May 13, 2020

SELL
$37.79 - $51.33 $73,199 - $99,426
-1,937 Reduced 13.51%
12,396 $554,000
Q4 2019

Feb 12, 2020

BUY
$42.46 - $50.46 $457,676 - $543,908
10,779 Added 303.29%
14,333 $715,000
Q3 2019

Nov 14, 2019

BUY
$40.12 - $45.47 $100,300 - $113,675
2,500 Added 237.19%
3,554 $158,000
Q2 2019

Aug 07, 2019

BUY
$37.28 - $41.68 $29,600 - $33,093
794 Added 305.38%
1,054 $44,000
Q1 2019

May 10, 2019

BUY
$35.49 - $43.02 $9,227 - $11,185
260 New
260 $0
Q1 2018

May 08, 2018

SELL
$32.97 - $36.63 $1.61 Million - $1.79 Million
-48,746 Closed
0 $0
Q4 2017

Feb 13, 2018

SELL
$32.09 - $34.78 $316,311 - $342,826
-9,857 Reduced 16.82%
48,746 $1.69 Million
Q3 2017

Nov 13, 2017

SELL
$28.96 - $34.0 $2.96 Million - $3.47 Million
-102,183 Reduced 63.55%
58,603 $1.99 Million
Q2 2017

Aug 14, 2017

BUY
N/A
160,786
160,786 $5.48 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.